fr 66973 has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T; Mabuchi, E; Mogami, H; Moriuchi, S; Park, K; Shimizu, K; Tamura, K; Yamada, M | 1 |
| Mabuchi, E; Matsui, Y; Mogami, H; Moriuchi, S; Park, K; Shimizu, K; Tamura, K; Yamada, M | 1 |
2 other study(ies) available for fr 66973 and Glioma
| Article | Year |
|---|---|
[Antitumor activity of FK973 for malignant gliomas and its assessment for normal brain cells].
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Glioma; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Oxazines | 1990 |
[Antitumor efficacy of FK 973 on malignant glioma cells].
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Glioma; Methotrexate; Mice; Mice, Inbred C3H; Nimustine; Oxazines | 1989 |